Enhabit (EHAB) Competitors

AdaptHealth (NASDAQ:AHCO) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Does the media refer more to AHCO or EHAB?

In the previous week, AdaptHealth had 1 more articles in the media than Enhabit. MarketBeat recorded 8 mentions for AdaptHealth and 7 mentions for Enhabit. AdaptHealth's average media sentiment score of 0.18 beat Enhabit's score of -0.04 indicating that AdaptHealth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Enhabit	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger earnings and valuation, AHCO or EHAB?

Enhabit has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.26B	0.41	-$678.90M	-$1.65	-6.08
Enhabit	$1.05B	0.36	-$80.50M	-$2.32	-3.21

Which has more volatility and risk, AHCO or EHAB?

AdaptHealth has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.84, indicating that its stock price is 84% more volatile than the S&P 500.

Is AHCO or EHAB more profitable?

AdaptHealth has a net margin of -6.57% compared to Enhabit's net margin of -11.24%. AdaptHealth's return on equity of 9.62% beat Enhabit's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-6.57%	9.62%	3.18%
Enhabit	-11.24%	1.67%	0.80%

Do analysts rate AHCO or EHAB?

AdaptHealth currently has a consensus target price of $12.17, suggesting a potential upside of 21.18%. Enhabit has a consensus target price of $9.35, suggesting a potential upside of 25.67%. Given Enhabit's higher possible upside, analysts plainly believe Enhabit is more favorable than AdaptHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
Enhabit	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

Do insiders & institutionals believe in AHCO or EHAB?

82.7% of AdaptHealth shares are held by institutional investors. 4.4% of AdaptHealth shares are held by insiders. Comparatively, 1.9% of Enhabit shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer AHCO or EHAB?

AdaptHealth received 78 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 60.45% of users gave AdaptHealth an outperform vote while only 11.54% of users gave Enhabit an outperform vote.

Company	Underperform	Outperform
AdaptHealth	Outperform Votes 81 60.45%	Underperform Votes 53 39.55%
Enhabit	Outperform Votes 3 11.54%	Underperform Votes 23 88.46%

Summary

AdaptHealth beats Enhabit on 14 of the 18 factors compared between the two stocks.